Real to get cracking on fracking

Published 30-OCT-2015 12:25 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Cooper Basin gas player Real Energy (ASX:RLE) has confirmed that it has found a drilling contractor for a long-awaited hydraulic fracturing campaign, and that the frac job will take place early next year.

Releasing its quarterly results before the market opened today, RLE said that it had completed a tender to a well stimulation services company, with it in the process of awarding the contract.

It is seeking to get cracking on a well stimulation of the Queenscliff-1 and Tamarama-1 wells, which at this stage is being designed as a five-stage frac job.

Both the wells tap the prolific Toolachee and Patchawarra formations, which have been tapped and fracced by explorers in the past.

RLE is currently studying cuttings from both wells for permeability and porosity in order to further refine the frac program.

It comes on the back of RLE announcing earlier this week that it had raised $2.6 million via a placement of 20.8 million shares.

The game plan

Both wells sit in the ATP927P permit, which is targeting the Windorah Trough in the Cooper Basin.

According the independent analysis, the contingent resource of the permit range from 77 billion cubic feet of gas on the more sure 1C category to 672Bcf on the 3C category.

On a prospective basis, the permit is thought to hold a recoverable resource of 5.4 trillion cubic feet of gas. The permit also has an in-place figure of 13.7Tcf, which was up 141% on previous estimates.

However, the estimates from DeGolyer and MacNaughton only take into account the current drilling on the permit.

A fracture stimulation of both Queenscliff-1 and Tamarama-1, and flow rates following the stimulation, would allow a firmer estimate of ultimate recoveries and flow rates.

It would also show potential gas offtake partner Incitec Pivot that gas can be reliably produced from the permit.

The chemicals giant hjas previously inked a letter of intent with the junior explorer for a deal worth a potential 110 petajoules of gas over 10 years.

The deal isn’t sealed as yet, but gives RLE something to aim for as it goes about firming up its resource.

The LOI was signed by the Incitec Pivot in a background where domestic gas supply on the east coast is expected to tighten considerably as a result of the ramp-up of LNG projects on the Queensland coast.

While those projects were expected to take gas from coal seam gas fields in Queensland, proponents have also sought to tie down separate third-party deals from the domestic market to shore up supply.

East coast gas demand profile

It has led to an environment where heavy users of gas, such as industrial players like Incitec Pivot, have sought to tie down deals with emerging oil and gas explorers in both proven and frontier basins for supply.

These deals will often be for a set price, giving the industrial player more comfort on the deal in an environment where gas prices are expected to rise despite a decline in oil prices.

For the explorer, it provides a more immediate path to commercialisation before exploration work has been done, giving it certainty.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free